Sanctuary Advisors LLC Acquires 159 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Sanctuary Advisors LLC lifted its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 5.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,335 shares of the company’s stock after purchasing an additional 159 shares during the period. Sanctuary Advisors LLC’s holdings in HealthEquity were worth $320,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. UMB Bank n.a. increased its stake in HealthEquity by 65.6% during the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after acquiring an additional 164 shares during the period. Quarry LP increased its stake in HealthEquity by 418.8% during the third quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after acquiring an additional 1,089 shares during the period. GAMMA Investing LLC increased its stake in HealthEquity by 32.9% during the fourth quarter. GAMMA Investing LLC now owns 1,248 shares of the company’s stock valued at $120,000 after acquiring an additional 309 shares during the period. Covestor Ltd increased its stake in HealthEquity by 27.4% during the third quarter. Covestor Ltd now owns 1,524 shares of the company’s stock valued at $125,000 after acquiring an additional 328 shares during the period. Finally, Wilmington Savings Fund Society FSB bought a new position in HealthEquity during the third quarter valued at about $150,000. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Trading Down 4.5 %

HQY stock opened at $104.82 on Tuesday. The business has a fifty day moving average price of $105.13 and a 200 day moving average price of $93.67. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $115.59. The stock has a market capitalization of $9.08 billion, a price-to-earnings ratio of 96.17, a P/E/G ratio of 1.60 and a beta of 0.55. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period last year, the firm earned $0.40 EPS. Analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Insider Activity

In other news, Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the sale, the director now directly owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now directly owns 78,219 shares of the company’s stock, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 39,000 shares of company stock valued at $3,895,788. Company insiders own 2.20% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the company. JMP Securities upped their price objective on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. Raymond James upped their price objective on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Tuesday, February 25th. Bank of America upped their price objective on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. Barrington Research upped their price objective on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Monday, December 2nd. Finally, Mizuho assumed coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective on the stock. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, HealthEquity has a consensus rating of “Moderate Buy” and an average price target of $113.54.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.